Dissecting the Decision: Investigators Discuss Current Management, Emerging Treatment Strategies and Novel Approaches in Gynecologic Cancers

Proceedings from an independent satellite symposium during the Society of Gynecologic Oncology’s 2017 Annual Meeting on Women’s Cancer. Featuring perspectives from Drs Michael Birrer, Bradley J Monk and Angeles Alvarez Secord.

1.25 AMA PRA Category 1 Credits^™

To complete the Post-test and Educational Assessment and Credit Form, click here. A statement of CME credit will be issued for scores of 80% or better. Your statement of credit will be mailed to you within 3 weeks or may be printed online.

Related links:

Home
CME evaluation
CME information and faculty disclosures
Select publications
PowerPoint slides

Case discussion: A 69-year-old woman with a right pelvic cystic mass, ascites and omental cake undergoes surgery followed by carboplatin/paclitaxel and experiences relapse 22 months after primary therapy
Presentation: Selection and Sequencing of Available Therapies for Patients with Ovarian Cancer – Dr Monk
Case discussion: A 50-year-old woman with widely metastatic Stage IVB cervical cancer and profuse vaginal bleeding receives chemotherapy with concurrent radiation therapy
Case discussion: A 65-year-old woman with a history of Stage IIIC2, Grade 2 endometrial cancer experiences metastatic recurrence and undergoes tumor testing for mismatch repair deficiency
Presentation: Current Systemic Treatment of Advanced Cervical Cancer and Endometrial Cancer – Dr Secord
Case discussion: A 70-year-old woman receives mirvetuximab soravtansine on protocol for recurrent serous ovarian cancer
Case discussion: A 68-year-old woman with recurrent fallopian tube cancer receives single-agent pembrolizumab on clinical trial
Presentation: Novel Investigational Agents in Development and Emerging Role of Immunotherapy in Gynecologic Cancers – Dr Birrer
Related symposium proceedings:
Dissecting the Decision: Investigators Discuss PARP Inhibition in the Management of Ovarian Cancer
1.75 Credits
Existing and Emerging Strategies in the Management of Patients with Uterine Sarcomas
2 Credits